$3.06 Billion is the total value of Discovery Value Fund's 18 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JKS | JINKOSOLAR HLDG CO LTDsponsored adr | $506,000 | -32.6% | 12,131 | 0.0% | 0.02% | -5.6% | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $112,000 | -31.7% | 3,544 | 0.0% | 0.00% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TESLA MTRS INC | 14 | Q4 2022 | 17.2% |
| SEA LTD | 13 | Q2 2023 | 34.7% |
| TELADOC HEALTH INC | 13 | Q3 2023 | 13.8% |
| JINKOSOLAR HLDG CO LTD | 12 | Q3 2021 | 2.2% |
| DOORDASH INC | 11 | Q3 2023 | 71.8% |
| SHOPIFY INC | 11 | Q2 2022 | 27.0% |
| INTELLIA THERAPEUTICS INC | 11 | Q3 2023 | 11.6% |
| LEXINFINTECH HLDGS LTD | 11 | Q2 2021 | 1.2% |
| ALIBABA GROUP HLDG LTD | 9 | Q2 2021 | 34.1% |
| FACEBOOK INC | 8 | Q3 2020 | 30.3% |
View Discovery Value Fund's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-14 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-10 |
View Discovery Value Fund's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.